FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Olopatadine Hydrochloride Ophthalmic Solution
Status: Discontinuation
»Therapeutic Categories: Ophthalmology

Expand all

Novartis (New 08/11/2020)

Company Contact Information:
888-669-6682

Presentation Posting Date Related Information
Pazeo Ophthalmic Solution 7mg/mL 2.5mL in 1 bottle (NDC 0065-4273-25) 08/11/2020 Discontinuation of this product is not due to manufacturing, product quality, safety, or efficacy concerns.
Pazeo Ophthalmic Solution 7mg/mL 5mL in 1 bottle (NDC 0065-4273-27) 08/11/2020 Discontinuation of this product is not due to manufacturing, product quality, safety, or efficacy concerns.

Teva Pharmaceuticals (New 04/27/2021)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
0.2%, 2.5 mL Bottle (NDC 0093-7684-32) 04/27/2021 Rx to OTC Switch. Current Rx customers on allocation through May 2021.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English